Outcomes, risks and complications of cardiac surgery for carcinoid heart disease

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 168-172

  Bhattacharyya, Sanjeev ^a   Raja, Shahzad G ^b   Toumpanakis, Christos ^a   Caplin, Martyn E ^a   Dreyfus, Gilles D ^b   Davar, Joseph ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

Carcinoid; Surgery; Valvular heart disease

Indexed keywords

CHROMOGRANIN A; SEROTONIN;

ACUTE KIDNEY FAILURE; ARTICLE; CARCINOID; CARCINOID SYNDROME; CARDIOVERSION; CAUSE OF DEATH; CLINICAL ARTICLE; COMPLETE HEART BLOCK; CORONARY ARTERY BYPASS GRAFT; HEART RIGHT VENTRICLE FAILURE; HEART VALVE SURGERY; HEART VENTRICLE TACHYCARDIA; HEMOFILTRATION; HUMAN; HYPOALBUMINEMIA; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; MORTALITY; PACEMAKER; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SEROTONIN BLOOD LEVEL; TREATMENT OUTCOME; TRICUSPID VALVE REPLACEMENT; VALVULAR HEART DISEASE;

AGED; CARCINOID HEART DISEASE; EPIDEMIOLOGIC METHODS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; PROGNOSIS; PULMONARY VALVE; TREATMENT OUTCOME; TRICUSPID VALVE;

EID: 79957985816     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.10.035     Document Type: Article

References (20)

1. Caplin M., Buscombe J., Hilson A., Jones A.L., Watkinson A.F., Burroughs A.K. Carcinoid tumour. Lancet 1998, 352:799-805.
2. Pellika P.A., Tajik A.J., Khandheria B.K., Seward J.B., Callahan J.A., Pitot H.C., Kvols L.K. Carcinoid heart disease: clinical and echocardiographic spectrum in 74 patients. Circulation 1993, 87:1188-1196.
3. Bhattacharyya S., Toumpanakis D., Caplin M.E., Davar J. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol 2008, 101:378-381.
4. Bhattacharyya S., Davar J., Dreyfus G., Caplin M.E. Carcinoid heart disease. Circulation 2007, 116:2860-2865.
5. Bhattacharyya S., Toumpanakis D., Burke M., Taylor A.M., Caplin M.E., Davar J. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ Cardiovasc Imaging 2010, 3:103-111.
6. Connolly H.M., Nishimura R.A., Smith H.C., Pellikka P.A., Mullany C.J., Kvols L.K. Outcome of cardiac surgery for carcinoid heart disease. J Am Coll Cardiol 1995, 25:410-416.
7. Moller J.E., Pellikka P.A., Bernheim A.M., Schaff H.V., Rubin J., Connolly H.M. Prognosis of carcinoid heart disease: an analysis of 200 cases over two decades. Circulation 2005, 112:3320-3327.
8. Robiolio P.A., Rigolin V.H., Harrison K.J., Lowe J.E., Moore J.O., Bashmore T.M., Feldman J.M. Predictors of outcome of tricuspid valve replacement in carcinoid heart disease. Am J Cardiol 1995, 75:485-488.
9. Castillo J.G., Filsoufi F., Rahmanian P.B., Anyanwu A., Zacks J.S., Warner R.P., Adams D.H. Early and late results of valvular surgery for carcinoid heart disease. J Am Coll Cardiol 2008, 51:1507-1509.
10. Zoghbi W., Enriquez-Sarano M., Foster E., Grayburn P.A., Kraft C.D., Levine R.A., Nihoyannopoulos P., Otto C.M., Quinones M.A., Rakowski H., Stewart W.J., Waggoner A., Weissman N.J. Recommendations for evaluation of the severity of native valvular regurgitation with two dimensional and doppler echocardiography. J Am Soc Echocardiogr 2003, 1:777-802.
11. Baumgartner H., Hung J., Bermejo J., Chambers J.B., Evangelista A., Griffin B.P., Lung B., Otto C.M., Pellikka P.A., Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009, 1:1-23.
12. Nashef S.A., Roques F., Michel P., Gauducheau E., Lemeshow S., Salamon R. European system for cardiac risk operative evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999, 16:9-13. the EuroSCORE study group.
13. O'Brien S.M., Shahian D.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B., Normand S.L., DeLong E.R., shewan C.M., Dokholyan R.S., Peterson E.D., Edwards F.H., Anderson R.P. Society of thoracic surgeons quality management task force. Ann Thorac Surg 2009, 88:s23-s42.
14. Zuetenhorst J., Korse C., Bonfrer J., Bakker R.H., Taal B. Role of natriuretic peptides in the diagnosis and treatment of patients with carcinoid heart disease. Br J Cancer 2004, 90:2073-2079.
15. Connolly H.M., Schaff H.V., Mullany C.J., Abel M.D., Pellikka P.A. Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling. Circulation 2002, 106:51-56.
16. Akerstrom G., Hellman P., Hessman O. Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol 2005, 19:717-728.
17. Ridker P.M., Chertow G.W., Karlson E.W., Neish A.S., Schoen F.J. Bioprosthetic tricuspid valve stenosis associated with extensive plaque deposition in carcinoid heart disease. Am Heart J 1991, 121:1835-1838.
18. Ohri S.K., Schofield J.B., Hodgson H., Oakley C.M., Keogh B.E. Carcinoid heart disease: early failure of an allograft valve replacement. Ann Thorac Surg 1994, 67:450-453.
19. Thorburn C.W., Morgan J.J., Shanahan M.X., Chang V.P. Long term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis. Am J Cardiol 1983, 51:1128-1132.
20. Brown M.L., Dearani J.A., Danielson G.K., Cetta F., Connolly H.M., Warnes C.A., Li Z., Hodge D.O., Driscoll D.J. Comparison of the outcome of porcine bioprosthetic versus mechanical prosthetic replacement of the tricuspid valve in Ebstein anomaly. Am J Cardiol 2009, 103:555-561.